SOURCE: Sunlight Research, LLC

Sunlight Research, LLC

September 28, 2010 16:22 ET

Sunlight Research Analyzes Impact of iPSC Patent Activity on Stem Cell Research

Live Webcast From World Stem Cell Summit in Detroit, Oct. 6, 2010, to Highlight Key Findings of Sunlight's Induced Pluripotent Stem Cell Patent Report

MINNEAPOLIS, MN--(Marketwire - September 28, 2010) - Sunlight Research™ -- The Source for Patent Analysis www.SunlightResearch.com, today announced the October 6, 2010 release of its Induced Pluripotent Stem Cell Patent Report analyzing this important stem cell technology segment. 

Stem cells have the remarkable potential to replace and rejuvenate injured, diseased and aging tissues. With the development of induced pluripotent stem cell (iPSC) technologies, differentiated cells with the exact genetic and immunological properties of a selected patient's cells can be reprogrammed to be stem cells, thereby eliminating problems of immunological rejection and viral contamination.

"Induced pluripotent stem cells may be developed for treatment of a multitude of diseases, including cardiovascular and neurological conditions" says Robin A. Chadwick, PhD, JD, a patent attorney and lead author of Sunlight's iPSC Patent Report. "In addition, iPSCs can end long waiting periods for organ transplants, and the use of immunosuppression drugs in transplant recipients. The process," she explains, "could be as simple as mixing a few cells from a patient with a [patented] cocktail of biological molecules, letting the cells grow up, and then injecting them into the patient."

Daniel A. Halpern, President of Sunlight Research, noted that "iPSCs represent a real game-changing technology, and one of the most exciting segments of the rapidly growing stem cell market." The overall global stem cell market is projected to reach $2.6 billion by 2012, and to exceed $5.1 billion by 2014, according to estimates by Business Insights, a market research firm. Other estimates show considerably larger global market forecasts. "The gold rush is on," Mr. Halpern added, "and many businesses and research institutions are staking claims to various aspects of iPSC technology, as evidenced by patent filings and issuances. Our mission is to shed light on these boundary-setting activities so that all stakeholders can make better decisions." 

Webinar October 6, 2010
The webinar, which will be webcast live from the World Stem Cell Summit in Detroit, is scheduled for 12:00pm EDT on Wednesday, October 6, 2010 and will highlight key findings of Sunlight's comprehensive claims-level analysis of the iPSC patent landscape, including issued patents and pending patent applications. Registration and report details are available online at iPSC Patent Report.

About Sunlight Research, LLC
Sunlight Research™ is the premier source for up-to-date Reports, Webinars and Educational Events concerning Patent Claims Coverage, Intellectual Property Market Research, Non-Practicing Entity ("Troll") Patent Reports and Interactive Freedom-To-Operate databases. Sunlight provides timely, in-depth and actionable patent analyses that are easily accessible and cost effective. A key feature of many Sunlight reports is an interactive freedom-to-operate tool, which allows customers to rapidly test various product designs for infringement against relevant patents. Sample reports are available at www.SunlightResearch.com

Register Today
iPSC Patent Report.

About the World Stem Cell Summit
The summit will attract more than 1,000 attendees from 30 nations, 60 exhibitors and more than 200 endorsing organizations and media partners. The largest and most comprehensive multi-track stem cell conference, the Summit features more than 150 international speakers and 50 hours of in-depth science, business and society presentations. www.worldstemcellsummit.com.

Keywords: Induced Pluripotent Stem Cells, iPSCs, stem cell patent, biotech, biotechnology, world stem cell summit, claims, transplants

Contact Information

  • Sunlight Research, LLC.
    900 2nd Avenue S., #490
    Minneapolis, MN 55402 U.S.A.
    Email Contact
    612-977-1713 -extension #3